List of Tables
    Table 1. Purpura Therapy Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Purpura Therapy Drugs Market Trends
    Table 3. Purpura Therapy Drugs Market Drivers
    Table 4. Purpura Therapy Drugs Market Challenges
    Table 5. Purpura Therapy Drugs Market Restraints
    Table 6. Global Purpura Therapy Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Purpura Therapy Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Purpura Therapy Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Purpura Therapy Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Purpura Therapy Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Purpura Therapy Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Purpura Therapy Drugs Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Purpura Therapy Drugs Sales by Manufacturer, (K Pcs), 2017-2022
    Table 14. Global Purpura Therapy Drugs Sales Share by Manufacturer, 2017-2022
    Table 15. Global Purpura Therapy Drugs Price by Manufacturer (2017-2022) & (USD/Pcs)
    Table 16. Global Purpura Therapy Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Purpura Therapy Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Purpura Therapy Drugs as of 2021)
    Table 18. Top Players of Purpura Therapy Drugs in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Purpura Therapy Drugs Product Type
    Table 20. Date of International Manufacturers Enter into Purpura Therapy Drugs Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Purpura Therapy Drugs Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Purpura Therapy Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Purpura Therapy Drugs Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Purpura Therapy Drugs Sales by Players, (K Pcs), 2020, 2021 & 2022
    Table 26. United States Purpura Therapy Drugs Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Purpura Therapy Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Purpura Therapy Drugs Sales in Volume by Region (2017-2022) & (K Pcs)
    Table 29. Global Purpura Therapy Drugs Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
    Table 30. Global Purpura Therapy Drugs Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Purpura Therapy Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Purpura Therapy Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 33. North America Purpura Therapy Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Purpura Therapy Drugs Sales in Volume by Region (2017-2028) & (K Pcs)
    Table 35. Asia Pacific Purpura Therapy Drugs Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Purpura Therapy Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 37. Europe Purpura Therapy Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Purpura Therapy Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 39. Latin Americaa Purpura Therapy Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Purpura Therapy Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 41. Middle East and Africa Purpura Therapy Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Bristol-Myers Squibb Company Corporation Information
    Table 43. Bristol-Myers Squibb Company Description and Business Overview
    Table 44. Bristol-Myers Squibb Company Purpura Therapy Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 45. Bristol-Myers Squibb Company Purpura Therapy Drugs Product
    Table 46. Bristol-Myers Squibb Company Recent Development
    Table 47. Pfizer Inc Corporation Information
    Table 48. Pfizer Inc Description and Business Overview
    Table 49. Pfizer Inc Purpura Therapy Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 50. Pfizer Inc Product
    Table 51. Pfizer Inc Recent Development
    Table 52. GlaxoSmithKline Plc Corporation Information
    Table 53. GlaxoSmithKline Plc Description and Business Overview
    Table 54. GlaxoSmithKline Plc Purpura Therapy Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 55. GlaxoSmithKline Plc Product
    Table 56. GlaxoSmithKline Plc Recent Development
    Table 57. Novartis AG Corporation Information
    Table 58. Novartis AG Description and Business Overview
    Table 59. Novartis AG Purpura Therapy Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 60. Novartis AG Product
    Table 61. Novartis AG Recent Development
    Table 62. Hovione Corporation Information
    Table 63. Hovione Description and Business Overview
    Table 64. Hovione Purpura Therapy Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 65. Hovione Product
    Table 66. Hovione Recent Development
    Table 67. Sanofi Winthrop Industrie S.A. Corporation Information
    Table 68. Sanofi Winthrop Industrie S.A. Description and Business Overview
    Table 69. Sanofi Winthrop Industrie S.A. Purpura Therapy Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 70. Sanofi Winthrop Industrie S.A. Product
    Table 71. Sanofi Winthrop Industrie S.A. Recent Development
    Table 72. Hoffman-L Roche Corporation Information
    Table 73. Hoffman-L Roche Description and Business Overview
    Table 74. Hoffman-L Roche Purpura Therapy Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 75. Hoffman-L Roche Product
    Table 76. Hoffman-L Roche Recent Development
    Table 77. Amgen Inc Corporation Information
    Table 78. Amgen Inc Description and Business Overview
    Table 79. Amgen Inc Purpura Therapy Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 80. Amgen Inc Product
    Table 81. Amgen Inc Recent Development
    Table 82. Grifols Biologicals Inc Corporation Information
    Table 83. Grifols Biologicals Inc Description and Business Overview
    Table 84. Grifols Biologicals Inc Purpura Therapy Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 85. Grifols Biologicals Inc Product
    Table 86. Grifols Biologicals Inc Recent Development
    Table 87. Ablynx NV Corporation Information
    Table 88. Ablynx NV Description and Business Overview
    Table 89. Ablynx NV Purpura Therapy Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 90. Ablynx NV Product
    Table 91. Ablynx NV Recent Development
    Table 92. Biogen Inc Corporation Information
    Table 93. Biogen Inc Description and Business Overview
    Table 94. Biogen Inc Purpura Therapy Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 95. Biogen Inc Product
    Table 96. Biogen Inc Recent Development
    Table 97. KM Biologics Corporation Information
    Table 98. KM Biologics Description and Business Overview
    Table 99. KM Biologics Purpura Therapy Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 100. KM Biologics Product
    Table 101. KM Biologics Recent Development
    Table 102. Lee's Pharmaceutical Holdings Ltd Corporation Information
    Table 103. Lee's Pharmaceutical Holdings Ltd Description and Business Overview
    Table 104. Lee's Pharmaceutical Holdings Ltd Purpura Therapy Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 105. Lee's Pharmaceutical Holdings Ltd Product
    Table 106. Lee's Pharmaceutical Holdings Ltd Recent Development
    Table 107. Omeros Corp Corporation Information
    Table 108. Omeros Corp Description and Business Overview
    Table 109. Omeros Corp Purpura Therapy Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 110. Omeros Corp Product
    Table 111. Omeros Corp Recent Development
    Table 112. Takeda Corporation Information
    Table 113. Takeda Description and Business Overview
    Table 114. Takeda Purpura Therapy Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 115. Takeda Product
    Table 116. Takeda Recent Development
    Table 117. Roch Corporation Information
    Table 118. Roch Description and Business Overview
    Table 119. Roch Purpura Therapy Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 120. Roch Product
    Table 121. Roch Recent Development
    Table 122. Key Raw Materials Lists
    Table 123. Raw Materials Key Suppliers Lists
    Table 124. Purpura Therapy Drugs Customers List
    Table 125. Purpura Therapy Drugs Distributors List
    Table 126. Research Programs/Design for This Report
    Table 127. Key Data Information from Secondary Sources
    Table 128. Key Data Information from Primary Sources
List of Figures
    Figure 1. Purpura Therapy Drugs Product Picture
    Figure 2. Global Purpura Therapy Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Purpura Therapy Drugs Market Size 2017-2028 (US$ Million)
    Figure 4. Global Purpura Therapy Drugs Sales 2017-2028 (K Pcs)
    Figure 5. United States Purpura Therapy Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Purpura Therapy Drugs Market Size 2017-2028 (US$ Million)
    Figure 7. United States Purpura Therapy Drugs Sales 2017-2028 (K Pcs)
    Figure 8. United States Purpura Therapy Drugs Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Purpura Therapy Drugs Market Share in Global, in Volume (K Pcs) 2017-2028
    Figure 10. Purpura Therapy Drugs Report Years Considered
    Figure 11. Product Picture of Allergic Purpura
    Figure 12. Product Picture of Thrombocytopenic Purpura
    Figure 13. Global Purpura Therapy Drugs Market Share by Type in 2022 & 2028
    Figure 14. Global Purpura Therapy Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Purpura Therapy Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Purpura Therapy Drugs Sales by Type (2017-2028) & (K Pcs)
    Figure 17. Global Purpura Therapy Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Purpura Therapy Drugs Price by Type (2017-2028) & (USD/Pcs)
    Figure 19. United States Purpura Therapy Drugs Market Share by Type in 2022 & 2028
    Figure 20. United States Purpura Therapy Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Purpura Therapy Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Purpura Therapy Drugs Sales by Type (2017-2028) & (K Pcs)
    Figure 23. United States Purpura Therapy Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Purpura Therapy Drugs Price by Type (2017-2028) & (USD/Pcs)
    Figure 25. Product Picture of Hospital Use
    Figure 26. Product Picture of Clinic Use
    Figure 27. Product Picture of Household
    Figure 28. Product Picture of Other
    Figure 29. Global Purpura Therapy Drugs Market Share by Application in 2022 & 2028
    Figure 30. Global Purpura Therapy Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 31. Global Purpura Therapy Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 32. Global Purpura Therapy Drugs Sales by Application (2017-2028) & (K Pcs)
    Figure 33. Global Purpura Therapy Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 34. Global Purpura Therapy Drugs Price by Application (2017-2028) & (USD/Pcs)
    Figure 35. United States Purpura Therapy Drugs Market Share by Application in 2022 & 2028
    Figure 36. United States Purpura Therapy Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 37. United States Purpura Therapy Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 38. United States Purpura Therapy Drugs Sales by Application (2017-2028) & (K Pcs)
    Figure 39. United States Purpura Therapy Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 40. United States Purpura Therapy Drugs Price by Application (2017-2028) & (USD/Pcs)
    Figure 41. North America Purpura Therapy Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 42. North America Purpura Therapy Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 43. U.S. Purpura Therapy Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Canada Purpura Therapy Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Europe Purpura Therapy Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 46. Europe Purpura Therapy Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 47. Germany Purpura Therapy Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. France Purpura Therapy Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. U.K. Purpura Therapy Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Italy Purpura Therapy Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Russia Purpura Therapy Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Asia-Pacific Purpura Therapy Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 53. Asia-Pacific Purpura Therapy Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 54. China Purpura Therapy Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Japan Purpura Therapy Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. South Korea Purpura Therapy Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. India Purpura Therapy Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Australia Purpura Therapy Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Taiwan Purpura Therapy Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Indonesia Purpura Therapy Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Thailand Purpura Therapy Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Malaysia Purpura Therapy Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Philippines Purpura Therapy Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Latin America Purpura Therapy Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 65. Latin America Purpura Therapy Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 66. Mexico Purpura Therapy Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Brazil Purpura Therapy Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Argentina Purpura Therapy Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Middle East & Africa Purpura Therapy Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 70. Middle East & Africa Purpura Therapy Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 71. Turkey Purpura Therapy Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Saudi Arabia Purpura Therapy Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. U.A.E Purpura Therapy Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Purpura Therapy Drugs Value Chain
    Figure 75. Purpura Therapy Drugs Production Process
    Figure 76. Channels of Distribution
    Figure 77. Distributors Profiles
    Figure 78. Bottom-up and Top-down Approaches for This Report
    Figure 79. Data Triangulation
    Figure 80. Key Executives Interviewed